FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

3813101000001102: APO-go 20mg/2mL injection

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    7531901000001116 APO-go 20mg/2mL injection en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    8171401000001111 APO-go 20mg/2mL injection en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    APO-go 20mg/2mL injection Is a Apomorphine hydrochloride 20mg/2mL injection - product false Inferred relationship Existential restriction modifier
    APO-go 20mg/2mL injection Availability Product is currently available false Additional relationship Existential restriction modifier
    APO-go 20mg/2mL injection NHS prescribing status NHS prescribable false Additional relationship Existential restriction modifier
    APO-go 20mg/2mL injection Legal category Prescription Only Medicine false Additional relationship Existential restriction modifier
    APO-go 20mg/2mL injection CSM recommendation to report adverse reactions Report only serious adverse reactions to the Committee on Safety of Medicines false Additional relationship Existential restriction modifier
    APO-go 20mg/2mL injection Product name type Brand name false Additional relationship Existential restriction modifier
    APO-go 20mg/2mL injection Has active ingredient Apomorphine hydrochloride false Inferred relationship Existential restriction modifier
    APO-go 20mg/2mL injection Has active ingredient Substance with chelating agent mechanism of action false Inferred relationship Existential restriction modifier
    APO-go 20mg/2mL injection Has active ingredient Central nervous system agent false Inferred relationship Existential restriction modifier
    APO-go 20mg/2mL injection Has active ingredient Emetic false Inferred relationship Existential restriction modifier
    APO-go 20mg/2mL injection Has active ingredient Antidote false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start